These reports have triggered an ongoing evaluation of the possible connection between GLP-1 medications and sudden loss of vision
The process varies by insurer, but the general steps are consistent: request the denial in writing (the insurer must provide the specific reason), have your prescriber write a letter of medical necessity that addresses the denial reason directly, include supporting clinical data (STEP, SURMOUNT, SELECT trial results), and submit within the appeal deadline (typically 60 to 180 days depending on the plan)
The debate over GLP-1s isnt just medical, its political
Many horses in regular work, travel, or competition experience changes in feeding schedule, stall confinement, or stress that can affect gastric and hindgut health
Individual variation of adipose gene expression and identification of covariated genes by cDNA microarrays